During the GLP-1 drug shortages of 2023 and 2024, compounding pharmacies stepped in to fill the gap, offering compounded semaglutide and tirzepatide at lower prices than brand-name versions
See appendices one and two to see reports from June and December
Clinical Effectiveness: SURMOUNT-1 Trial (Tirzepatide 15 mg): Duration: 72 weeks Participants: 2,539 adults with obesity Average Weight Loss: 22.5% of body weight 10 mg Dose: 21.4% weight loss 5 mg Dose: 15.0% weight loss Placebo: 2.4% weight loss 5% Weight Loss: 96% of participants 10% Weight Loss: 89% of participants 15% Weight Loss: 78% of participants 20% Weight Loss: 63% of participants This is the best weight loss result ever achieved with medication in clinical trials
It prompts the pancreas to release insulin when blood sugar is high, suppresses glucagon, and slows digestion actions that work together to lower blood sugar while reducing the risk of hypoglycemia
Long-Term Phase: Achieving and Maintaining Goals Once youve been on Tirzepatide for a longer period, your focus might shift
Duration Comparison Across Receptor Agonists Key Takeaway On Retatrutides Half-Life Retatrutide maintains an extended half-life ranging from approximately 6 to 8 days, positioning it as a strong contender among modern metabolic therapies